Development Of An Optimal F/hn Pseudotyped Siv Vector For Cf Gene Therapy

S. Hyde; E. Alton; A. Boyd; M. Connolly; M. Chan; J. Davies; L. Davies; S. Gea-sorli; U. Griesenbach; M. Hasegawa; J. Innes; M. Inoue; G. Mclachlan; C. Meng; I. Pringle; S. Sumner-jones; S. Tsugumine; D. Gill

doi:10.1136/thoraxjnl-2014-206260.332

Development Of An Optimal F/hn Pseudotyped Siv Vector For Cf Gene Therapy

S. Hyde, E. Alton, A. Boyd, M. Connolly, M. Chan, J. Davies, L. Davies, S. Gea-sorli, U. Griesenbach, M. Hasegawa, J. Innes, M. Inoue, G. Mclachlan, C. Meng, I. Pringle, S. Sumner-jones, S. Tsugumine, D. Gill

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	A165-A166
Journal	Thorax
Volume	69
Issue number	Suppl 2
DOIs	https://doi.org/10.1136/thoraxjnl-2014-206260.332
Publication status	Published - 1 Dec 2014
Externally published	Yes

Access to Document

10.1136/thoraxjnl-2014-206260.332

http://thorax.bmj.com/cgi/doi/10.1136/thoraxjnl-2014-206260.332

Cite this

Hyde, S., Alton, E., Boyd, A., Connolly, M., Chan, M., Davies, J., Davies, L., Gea-sorli, S., Griesenbach, U., Hasegawa, M., Innes, J., Inoue, M., Mclachlan, G., Meng, C., Pringle, I., Sumner-jones, S., Tsugumine, S., & Gill, D. (2014). Development Of An Optimal F/hn Pseudotyped Siv Vector For Cf Gene Therapy. Thorax, 69(Suppl 2), A165-A166. https://doi.org/10.1136/thoraxjnl-2014-206260.332

@article{9e268610e36c42849c9cd8bbd7322d29,

title = "Development Of An Optimal F/hn Pseudotyped Siv Vector For Cf Gene Therapy",

author = "S. Hyde and E. Alton and A. Boyd and M. Connolly and M. Chan and J. Davies and L. Davies and S. Gea-sorli and U. Griesenbach and M. Hasegawa and J. Innes and M. Inoue and G. Mclachlan and C. Meng and I. Pringle and S. Sumner-jones and S. Tsugumine and D. Gill",

year = "2014",

month = dec,

day = "1",

doi = "10.1136/thoraxjnl-2014-206260.332",

language = "English",

volume = "69",

pages = "A165--A166",

journal = "Thorax",

issn = "0040-6376",

publisher = "BMJ Publishing Group",

number = "Suppl 2",

}

Hyde, S, Alton, E, Boyd, A, Connolly, M, Chan, M, Davies, J, Davies, L, Gea-sorli, S, Griesenbach, U, Hasegawa, M, Innes, J, Inoue, M, Mclachlan, G, Meng, C, Pringle, I, Sumner-jones, S, Tsugumine, S & Gill, D 2014, 'Development Of An Optimal F/hn Pseudotyped Siv Vector For Cf Gene Therapy', Thorax, vol. 69, no. Suppl 2, pp. A165-A166. https://doi.org/10.1136/thoraxjnl-2014-206260.332

TY - JOUR

T1 - Development Of An Optimal F/hn Pseudotyped Siv Vector For Cf Gene Therapy

AU - Hyde, S.

AU - Alton, E.

AU - Boyd, A.

AU - Connolly, M.

AU - Chan, M.

AU - Davies, J.

AU - Davies, L.

AU - Gea-sorli, S.

AU - Griesenbach, U.

AU - Hasegawa, M.

AU - Innes, J.

AU - Inoue, M.

AU - Mclachlan, G.

AU - Meng, C.

AU - Pringle, I.

AU - Sumner-jones, S.

AU - Tsugumine, S.

AU - Gill, D.

PY - 2014/12/1

Y1 - 2014/12/1

U2 - 10.1136/thoraxjnl-2014-206260.332

DO - 10.1136/thoraxjnl-2014-206260.332

M3 - Article

VL - 69

SP - A165-A166

JO - Thorax

JF - Thorax

SN - 0040-6376

IS - Suppl 2

ER -